Eliquent

End-to-end CGT & ATMP consulting—from regulatory strategy to implementation and lifecycle support.

The page says the FDA uses AI to review submissions, competitors use the same AI models, and users remain liable for incorrect outputs.

The page lists a QMSR info sheet and Quality & Compliance and QMSR capabilities.

The page lists a Regulatory Writing info sheet and Regulatory Affairs and Regulatory Writing capabilities.

Listen as former FDA senior officials share valuable perspectives and behind-the-scenes insights on the FDA’s transition to a new presidential administration.

ELIQUENT’s LDT Resource Hub provides expert-driven content and insights on the evolving LDT landscape.

Biopharmaceutical organizations face increasing regulatory scrutiny and increasingly complex safety data.

ELIQUENT’s regulatory resources include a curated library of materials about its expertise, services, and approach.

ELIQUENT Life Sciences announced a news item about Celia Witten, M.D., Ph.D., a former Deputy Director at the U.S. Food and Drug Administration.

ELIQUENT Life Sciences announced its acquisition of Azzur Consulting, strengthening its quality and compliance capabilities.

The page discusses a strategic focus on autoimmune diseases and cites a news article about eight development products in the field.

ELIQUENT offers radiopharmaceutical solutions.

ELIQUENT offers careers in life sciences consulting.

The ELIQUENT Experts Council comprises former regulators and industry leaders who pressure-test strategy and help mitigate risk.

Jeff Boyd leads ELIQUENT’s global CDMO business, bringing together its Regulatory, Quality & Compliance, and GxP Engineering capabilities.

As a Partner at ELIQUENT Life Sciences, Dr. Lynne Ensor provides strategic regulatory and compliance consulting to the pharmaceutical and biotechnology sectors.

Marissa is a Senior Vice President in the Quality and Compliance Practice who provides strategic guidance to life science companies.

ELIQUENT Life Sciences provides consulting in regulatory affairs, pharmacovigilance, and quality.

Eliquent integrates Environmental, Social, and Governance principles into its operations.

ELIQUENT Life Sciences delivers the answers and solutions global life sciences companies need to gain and maintain market authorization for their products.

ELIQUENT Life Sciences, Inc. and its subsidiaries state that they respect individuals’ right to privacy.

ELIQUENT Life Sciences adds Dr. Wendy Sanhai to its board. Sanhai was a senior director at GlaxoSmithKline.

Feb 2025 · Medical Product OutsourcingNews article

ELIQUENT Life Sciences names Rob Wojciechowski chief operations officer. The company describes itself as a global regulatory, quality, and safety consulting firm.

Feb 2025 · financialpostNews article

Rob Wojciechowski joins ELIQUENT Life Sciences to lead the company’s consulting practice in Europe and Asia.

Dec 2024 · Medical Product OutsourcingNews article

ELIQUENT Life Sciences has recruited former FDA senior executives John Taylor and Michele Dougherty to its C-suite. The two executives now lead ELIQUENT’s Quality and Regulatory practice areas.

May 2024 · Medical Product OutsourcingNews article